ALSV
ATP Life Science Ventures Portfolio holdings
AUM
$898M
This Quarter Return
+36.43%
1 Year Return
+84.86%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$742M
AUM Growth
+$742M
(+41%)
Cap. Flow
+$12.8M
Cap. Flow
% of AUM
1.72%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
2
New
–
Increased
1
Reduced
–
Closed
–
Top Buys
| 1 |
Akero Therapeutics
AKRO
|
$12.8M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Stoke Therapeutics
STOK
$1.08B
| $562M | 75.8% | 16,786,713 | – | – |
|
|
2
Akero Therapeutics
AKRO
$3.74B
| $180M | 24.2% | 5,830,203 +415,000 | +8% | +$12.8M |
|